Circle Internet Group Inc. Class A Common Stock vs Eli Lilly And Co — how do they compare? Circle Internet Group Inc. Class A Common Stock trades at $84.72 (market cap $20.52B), while Eli Lilly And Co trades at $1,177.77 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 50.7× Circle Internet Group Inc. Class A Common Stock's market cap, and Eli Lilly And Co pays a 0.59% dividend while Circle Internet Group Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Circle Internet Group Inc. Class A Common Stock for 0 Days and Eli Lilly And Co for 93 Days on average.
| CRCL | LLY | |
|---|---|---|
Market Cap | $20.52B | $1.04T |
Volume | 9,813,610 | 3,064,878 |
Sector | Financials | Health |
52-Week High | $150.48 | $1.28K |
52-Week Low | $50.23 | $799.57 |
Typical Hold Time | 0 Days | 93 Days |
Enterprise Value | $19.03B | $1.09T |
Dividend Yield | — | 0.59% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,179.27, down 0.79% on the day, with a bullish technical outlook and strong fundamental momentum. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $8.38 surpassing the $6.40 expectation. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Recent news highlights promising pipeline developments in weight-loss and diabetes drugs, reinforcing its market leadership.
The outlook remains positive given robust revenue growth, high profitability, and analyst consensus favoring buys. Key risks include competitive pressures in the obesity drug market and execution challenges in scaling production. With a consensus price target of $1,350, representing ~14% upside, the stock offers growth potential but requires monitoring of pipeline progress and market dynamics.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Circle Internet Group provides internet financial infrastructure centered on its stablecoin network. Its business includes stablecoins, blockchain infrastructure for developers, digital-asset services, and payment applications.
Read more on CRCL →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →